辅助化疗

在未进展为MM之前，辅助化疗的意义仍未明确。

The mechanism of adjuvant chemotherapy remains unclear before progression to MM .

ET方案密集新辅助化疗对乳腺癌治疗的临床疗效观察

Therapeutic Efficacy of the New Adjuvant Chemotherapy with Dose-dense ET Regime in Breast Cancer

紫杉醇联合卡铂新辅助化疗Ⅱb期宫颈癌50例

Neoadjuvant Chemotherapy with Paclitaxel and Carboplatin for 50 Cases with Cervical Cancer Stage ⅱ b

乳腺癌新辅助化疗后血流动力学变化的动态增强MRI研究

Breast cancer after neoadjuvant chemotherapy : alteration of kinetic characteristics in dynamic contrast-enhanced MR imaging

新辅助化疗诱导结肠癌细胞凋亡及IκBαmRNA的表达

Apoptosis of Colon Cancer Cells and Expression of I κ B α - mRNA Induced by Neo-adjuvant Chemotherapy

Ⅲ期乳腺癌术前应用CAP方案辅助化疗36例

Application of CAP Regimen Auxilliary Chemotherapy on Preoperation Mastocarcinoma

新辅助化疗后放射治疗≥N2期鼻咽癌的临床研究

Neoadjuvant Chemotherapy ( Plus Radiotherapy ) in the Treatment of Patients with N2 Nasopharyngeal Carcinoma - A Randomized Clinical Study

Survivin在乳腺癌新辅助化疗中的预期意义

Predictive significance of survivin in breast cancer response to neoadjuvant chemotherapy

Dukes'B期结直肠癌术后辅助化疗的Meta分析

Meta-analysis of Postoperative Adjuvant Chemotherapy for Dukes ' B Colorectal Carcinoma

目的察CAP方案在Ⅲ期乳腺癌术前新辅助化疗的近期疗效及毒副反应。

Objective Observe the effect and side effect of CAP regimen auxilliary chemotherapy in treating mastocarcinoma ⅲ .

新辅助化疗对浸润性膀胱癌预后影响的Meta分析

Meta-Analysis of effect of adjuvant chemotherapy on prognosis of muscular-invasive bladder cancer

结直肠癌5-FU和亚叶酸辅助化疗的评价

Appraisal of Adjuvant 5-Fluorouracil and Folinic Acid in Colorectal Cancer

结果经新辅助化疗后，乳腺癌原发灶明显缩小，11%达到完全缓解（CR）；

Results After neoadjuvant chemotherapy , the primary cancer became smaller , 11 % of them was completely release ( CR );

新辅助化疗前后PCNA和p53在口腔鳞癌中的表达及其对化疗敏感性的预测研究

Expression of PCNA and p53 in oral squamous cell carcinoma for prediction of response to neoadjuvant chemotherapy

结直肠癌术后早期应用奥沙利铂联合5-FU辅助化疗的安全性

Safety of post-operative application of oxaliplatin combined with 5-FU / in patients with colorectal cancer

结论胃癌患者存在先天性多药耐药现象，术前检测P-糖蛋白与突变型p53的表达对胃癌的新辅助化疗具有重要的指导作用。

Conclusion The expression of p53 and P-glycoprotein before operation might be helpful for guidance of chemotherapy in patients with gastric cancer .

谷胱甘肽对T3期直肠癌新辅助化疗患者的保护作用

Glutathione Provides Protection for Patients with T3 Stage Rectal Cancer During Neoadjuvant Chemotherapy

目的明确乳腺癌新辅助化疗后动态增强MRI表现强化特征的变化规律。

Objective To investigate the alteration of kinetic enhancement of breast cancer after neoadjuvant chemotherapy ( NACT ) by dynamic contrast-enhanced MR imaging ( DCE-MRI ) .

新辅助化疗FEC方案和TEC方案对乳腺癌患者的疗效

Efficacy of neoadjuvant chemotherapy with FEC and TEC regimen on breast cancer

结论：1.新辅助化疗能有效降低ki-67指数表达，显著抑制肿瘤细胞的增殖活性。

Neoadjuvant chemotherapy can significantly inhibit tumor cell proliferation by reducing the expression of ki-67.2 .

结论：新辅助化疗前后同一大肠癌患者MVD有明显变化。

Conclusions : The MVD degree of large intestine cancer can be decreased by new supplementary chemotherapy .

CAF与CMF方案用于局部晚期乳腺癌新辅助化疗临床观察

Evaluation of CAF and CMF regimen neoadjuvant chemotherapy for local advanced breast cancer

结论：PF方案的新辅助化疗结合放射治疗可以提高上段食管癌的疗效。

Conclusions : Neoadjuvant chemotherapy with PF regimen plus radiotherapy may improve the outcome of upper esophageal carcinoma .

二氢嘧啶脱氢酶活性与结直肠癌患者5-FU辅助化疗毒性关系的研究

Relationship between Dihydropyrimidine Dehydrogenase ( DPD ) Activity and Toxicity of 5-FU-based Adjuvant Chemotherapy in Colorectal Cancer Patients

子宫内膜癌辅助化疗和放疗后发生的Guillain-Barre综合征

Guillain-Barre syndrome occurring after adjuvant chemo - radiotherapy for endometrial cancer

结论TP方案新辅助化疗治疗Ⅲ、Ⅳ期乳腺癌的疗效肯定，不良反应可耐受。

Conclusion TP neoadjuvant chemotherapy regimen cures the cancerous mammary glands at period III and IV well with tolerable adverse effects .

对EGFR的抑制对于这个前景黯淡的疾病来说，不失为一个有希望的辅助化疗手段。

Inhibition of EGFR may be a promising adjuvant in chemotherapeutic strategy in the treatment of the dismal disease .

口腔鳞癌对卡铂联合5-Fu新辅助化疗方案敏感性的预测研究

Prediction of chemosensitivity to combination neoadjuvant chemotherapy with carboplatin and 5-Fu for the patients with oral squamous cell carcinoma

术后替加氟辅助化疗对Ro切除的食管鳞癌患者生存率的影响

Influence of survival rate on postoperative tegafur adjuvant chemotherapy in patients with squamous cell carcinoma undergoing Ro resection

经新辅助化疗后，MVD、PCNA变化不明显的患者预后不良。

Following new supplementary chemotherapy the patients who with less decreasing of MVD and PCNA will have a bad prognosis .